X.-P. Hui et al. / Tetrahedron 64 (2008) 2553e2558
2557
24H, CH3). 13C NMR (100 MHz, CDCl3) d: 166.85, 134.89,
129.83, 128.74, 125.52, 77.16, 52.94, 38.37, 27.86, 27.71,
24.96, 24.14, 21.55, 7.85, 7.51. IR (KBr): 3432, 3315, 2964,
2878, 1640, 1583, 1531, 1467, 718 cmꢂ1. Anal. Calcd for
C28H48N2O4: C, 70.55; H, 10.15; N, 5.88. Found: C, 70.31;
H, 9.83; N, 5.58.
4.2.4. Synthesis of chiral ligands 3g and 3h
To a solution of 4 (1.03 g, 4.41 mmol) in CH2Cl2 (25 mL)
at ꢂ78 ꢀC, n-butyllithium solution (2.5 M, 2.11 mL,
5.3 mmol) was added and the mixture was stirred for 0.5 h.
A solution of isophthalyl chloride (0.90 g, 4.41 mmol) in
CH2Cl2 (25 mL) was added to the above solution. The result-
ing solution was allowed to warm to room temperature and
stirred for 18 h. This mixture was added slowly in 0.5 h to a so-
lution of NEt3 (1.85 mL, 13.2 mmol), a catalytic amount of
DMAP, and amino alcohol 2b (1.09 g, 5.29 mmol) in
CH2Cl2 (20 mL) at room temperature. The solution was stirred
overnight and then washed with 1 M HCl (3ꢁ25 mL), and
brine (3ꢁ25 mL). The organic phase was dried over anhydrous
MgSO4 and the solvent was removed under reduced pressure
to give a yellow residue. The crude product was purified by
flash column chromatography to afford 3g and 3h.
4.2.2.5. N1,N3-Bis[(S)-1-hydroxy-3-phenylpropan-2-yl]isoph-
thalamide (3e). White powder, yield 53%, mp 151e152 ꢀC.
[a]2D5 ꢂ129 (c 1.00, DMSO). H NMR (300 MHz, DMSO-
1
d6) d: 8.29 (d, J¼9.0 Hz, 2H, NH), 8.16 (s, 1H, ArH), 7.85
(d, J¼7.5 Hz, 2H, ArH), 7.48 (t, J¼7.5 Hz, 1H, ArH), 7.24e
7.12 (m, 10H, ArH), 4.89 (t, J¼5.7 Hz, 2H, OH), 4.16e4.14
(m, 2H, CH), 3.55e3.28 (m, 4H, CH2), 2.93 (dd, J¼13.5,
4.8 Hz, 2H, PhCH2), 2.77 (dd, J¼13.5, 8.7 Hz, 2H, PhCH2).
13C NMR (75 MHz, DMSO-d6) d: 166.63, 139.84, 135.42,
130.28, 129.73, 128.83, 126.99, 126.68, 63.49, 53.96, 37.10.
IR (KBr): 3414, 3343, 2958, 1633, 1547, 1452, 730 cmꢂ1
.
4.2.4.1. 1,3-Bis[(S)-4-benzyl-5,5-diethyloxooxazolidin-3-formyl]-
Anal. Calcd for C26H28N2O4: C, 72.20; H, 6.53; N, 6.48.
Found: C, 72.01; H, 6.84; N, 6.48.
benzene (3g). White powder, yield 21%, mp 61e62 ꢀC. [a]D25
1
þ29 (c 1.00, CH2Cl2). H NMR (400 MHz, CDCl3) d: 7.90
(s, 1H, ArH), 7.73 (d, J¼8.0 Hz, 2H, ArH), 7.39 (t, J¼8.0 Hz,
1H, ArH), 7.27e7.13 (m, 10H, ArH), 4.77e4.74 (m, 2H, CH),
3.23 (dd, J¼14.0, 5.2 Hz, 2H, PhCH2), 2.91 (dd, J¼14.0,
8.4 Hz, 2H, PhCH2), 1.98e1.92 (m, 2H, CH2), 1.66e1.58 (m,
4H, CH2), 1.50e1.43 (m, 2H, CH2), 0.95 (t, J¼7.6 Hz, 6H,
CH3), 0.75 (t, J¼7.6 Hz, 6H, CH3). 13C NMR (100 MHz,
CDCl3) d: 168.71, 152.40, 136.49, 133.12, 132.77, 130.63,
129.07, 128.64, 127.00, 126.90, 86.67, 61.75, 34.62, 29.12,
25.65, 7.74, 7.24. IR (KBr): 2975, 2944, 2885, 1781, 1683,
1458, 1356, 1301, 724 cmꢂ1. Anal. Calcd for C36H40N2O6: C,
72.46; H, 6.76; N, 4.69. Found: C, 72.27; H, 6.81; N, 4.74.
4.2.2.6. N1,N3-Bis[(1R,2S)-1-hydroxy-1,3-diphenylpropan-2-
yl]isophthalamide (3f). White powder, yield 84%, mp 110e
111 ꢀC. [a]D25 ꢂ91 (c 1.00, CH2Cl2). 1H NMR (300 MHz,
CDCl3) d: 7.69 (s, 1H, ArH), 7.39e7.01 (m, 23H, ArH),
6.38 (d, J¼8.1 Hz, 2H, NH), 5.06 (d, J¼2.7 Hz, 2H, CH),
4.60e4.52 (m, 2H, CH), 2.80e2.77 (m, 4H, CH2). 13C
NMR (75 MHz, CDCl3) d: 167.74, 141.27, 138.70, 134.35,
129.27, 129.11, 128.66, 128.37, 127.74, 126.60, 126.34,
125.90, 75.29, 57.68, 33.15. IR (KBr): 3409, 3061, 3028,
1643, 1519, 1450, 749 cmꢂ1. Anal. Calcd for C38H36N2O4:
C, 78.06; H, 6.21; N, 4.79. Found: C, 77.77; H, 6.31;
N, 4.72.
4.2.4.2. 3-[(S)-4-Benzyl-5,5-diethyloxooxazolidin-3-formyl]-N-
[(S)-3-ethyl-3-hydroxy-1-phenylpentan-2-yl]-benzamide (3h).
White powder, yield 25%, mp 63e64 ꢀC. [a]D25ꢂ54 (c 1.00,
4.2.3. Preparation of (S)-4-benzyl-5,5-diethyloxazolidin-2-
one (4)
1
CH2Cl2). H NMR (400 MHz, CDCl3) d: 7.76 (s, 1H, ArH),
To a solution of 2b (1.03 g, 5.0 mmol) and triethylamine
(3.48 mL, 25 mmol) in THF (25 mL), ethyl chloroformate
(0.48 mL, 5.0 mmol) was added at room temperature and
the mixture was allowed to react for 3 h. The solution was
7.66 (d, J¼8.0 Hz, 2H, ArH), 7.39 (t, J¼8.0, 1H, ArH),
7.34e7.14 (m, 10H, ArH), 6.22 (d, J¼9.2 Hz, 1H, NH),
4.83e4.79 (m, 1H, CH), 4.33e4.29 (m, 1H, CH), 3.27 (dd,
J¼5.2, 14.0 Hz, 1H, PhCH2), 3.14 (dd, J¼14.0, 3.6 Hz, 1H,
PhCH2), 2.98 (dd, J¼14.0, 8.8 Hz, 1H, PhCH2), 2.87 (dd,
J¼14.0, 10.4 Hz, 1H, PhCH2), 2.51 (br, 1H, OH), 1.79e1.50
(m, 8H, CH2), 1.04e0.80 (m, 12H, CH3). 13C NMR
(100 MHz, CDCl3) d: 169.01, 166.89, 152.48, 138.73,
136.48, 134.47, 133.52, 131.77, 130.55, 129.17, 129.13,
128.68, 128.46, 127.89, 127.59, 126.99, 126.37, 86.90,
76.95, 61.65, 56.82, 35.11, 34.67, 29.12, 28.11, 27.82,
25.57, 8.03, 7.77, 7.67, 7.28. IR (KBr): 3383, 2970, 2941,
2882, 1781, 1684, 1642, 1536, 1357, 729 cmꢂ1. Anal. Calcd
for C35H42N2O5: C, 73.66; H, 7.42; N, 4.91. Found: C,
73.63; H, 7.38; N, 4.80.
then added slowly to
a suspension of NaH (1.20 g,
50 mmol) in THF (25 mL) during a period of 0.5 h and the re-
sulting mixture was refluxed for 12 h. The solution was cooled
down and washed with 1 M HCl (3ꢁ50 mL) and brine
(3ꢁ50 mL), then the organic phase was dried over anhydrous
MgSO4, and the solvent was removed to give yellowish oil 4
in 88% yield. [a]2D5 ꢂ66 (c 1.00, CH2Cl2). 1H NMR
(300 MHz, CDCl3) d: 7.37e7.16 (m, 5H, ArH), 4.96 (br,
1H, NH), 3.76 (dd, J¼11.1, 3.6 Hz, 1H, CH), 2.86 (dd,
J¼3.0, 14.4 Hz, 1H, PhCH2), 2.70 (dd, J¼14.4, 12.9 Hz,
1H, PhCH2), 1.98e1.91 (m, 1H, CH2), 1.84e1.68 (m, 3H,
CH2), 1.06 (t, J¼7.5 Hz, 3H, CH3), 0.97 (t, J¼7.5 Hz, 3H,
CH3). 13C NMR (75 MHz, CDCl3) d: 157.99, 137.10,
128.88, 128.74, 126.95, 87.22, 60.86, 37.08, 28.99, 24.89,
7.65, 7.37. IR (KBr): 3272, 2973, 1747, 1604, 1495, 1457,
1388, 739 cmꢂ1. MS (EI) m/z: 234.0 (47.5), 141.8 (72.7),
97.8 (100), 90.8 (63.1).
4.3. General procedure for asymmetric addition of
phenylacetylene to aldehydes
Under dry nitrogen, the ligand (0.025 mmol) and Ti-
(O-i-Pr)4 (0.075 mmol) were mixed in the solvent (1.5 mL)